High-throughput screening identifies compounds that enhance lentiviral transduction

Gene Ther. 2014 Dec;21(12):1008-20. doi: 10.1038/gt.2014.80. Epub 2014 Sep 18.


A difficulty in the field of gene therapy is the need to increase the susceptibility of hematopoietic stem cells (HSCs) to ex vivo genetic manipulation. To overcome this obstacle a high-throughput screen was performed to identify compounds that could enhance the transduction of target cells by lentiviral vectors. Of the 1280 compounds initially screened using the myeloid-erythroid-leukemic K562 cell line, 30 were identified as possible enhancers of viral transduction. Among the positive hits were known enhancers of transduction (camptothecin, etoposide and taxol), as well as the previously unidentified phorbol 12-myristate 13-acetate (PMA). The percentage of green fluorescent protein (GFP)-positive-expressing K562 cells was increased more than fourfold in the presence of PMA. In addition, the transduction of K562 cells with a lentiviral vector encoding fVIII was four times greater in the presence of PMA as determined by an increase in the levels of provirus in genetically modified cells. PMA did not enhance viral transduction of all cell types (for example, sca-1(+) mouse hematopoietic cells) but did enhance viral transduction of human bone marrow-derived CD34(+) cells. Notably, the percentage of GFP-positive CD34(+) cells was increased from 7% in the absence of PMA to greater than 22% in the presence of 1 nM PMA. PMA did not affect colony formation of CD34(+) cells or the expression of the hematopoietic markers CD34 and CD45. These data demonstrate that high-throughput screening can be used to identify compounds that increase the transduction efficiency of lentiviral vectors, identifying PMA as a potential enhancer of lentiviral HSC transduction.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigens, CD34 / metabolism
  • Camptothecin / pharmacology
  • Cell Line, Tumor
  • Colforsin / pharmacology
  • Genetic Therapy
  • Genetic Vectors / genetics
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • HEK293 Cells
  • Hematopoietic Stem Cells / metabolism
  • High-Throughput Screening Assays / methods*
  • Humans
  • Lentivirus / genetics*
  • Mice
  • NIH 3T3 Cells
  • Sirolimus / pharmacology
  • Tetradecanoylphorbol Acetate / analogs & derivatives
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transduction, Genetic*
  • U937 Cells


  • Antigens, CD34
  • Green Fluorescent Proteins
  • Colforsin
  • phorbolol myristate acetate
  • Tetradecanoylphorbol Acetate
  • Sirolimus
  • Camptothecin